The Surgeon General's call to action to prevent and decrease overweight and obesity/Office of Disease Prevention and Health Promotion; Centers for Disease Control and Prevention, National Institutes of Health. [Rockville, MD]: U.S. Dept. of Health and Human Services, Public Health Service, Office of the Surgeon General; Washington, D.C., 2001.
World Health Organization. European charter on counteracting obesity. WHO Ministerial Conference on Counteracting Obesity: diet and physical activity for health. Istanbul, Turkey, 15-17 Nov., 2006.\; accessible at: http://www.euro.who.int/physicalactivity/policies/20090428_1.
World Health Organization. WHO Global Infobase: country collected data, 2010. Accessible at: https://apps.who.int/infobase/comparestart.aspx. Accessed 23 Feb 2012.
Wang Y, Beydoun MA. The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiologic Rev. 2007;29(1):6–28.
Flegal KM, Carroll M, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2008. JAMA. 2010;303(3):235–41.
World Health Organization. Obesity and overweight—fact sheet No. 311. 2006. Accessible at: http://www.who.int/mediacentre/factsheets/fs311/en/index.html. Accessed 23 Feb 2012.
US Department of Health and Human Services. National Institutes of Health. Overweight and obesity statistics. WIN Weight-control information network 2010. Accessible at: http://win.niddk.nih.gov/statistics/index.htm. Accessed 23 Feb 2012.
Centers for Disease Control and Prevention. National Center for Health Statistics. Prevalence of overweight, obesity and extreme obesity among adults: United States, trends 1960–1962 through 2005–2006. Health E-Stats 2008; Dec. Accessible at: http://www.cdc.gov/nchs/data/hestat/overweight/overweight_adult.htm. Accessed 23 Feb 2012.
Centers for Disease Control. Behavioral Risk Factor Surveillance System (BRFSS). Differences in prevalence of obesity among Black, White, and Hispanic adults—United States, 2006–2008. Accessible at: http://www.cdc.gov/brfss. Accessed 23 Feb 2012.
Fontaine KR, Bartlett SJ. Access and use of medical care among obese persons. Obesity Res. 2000;8:403–6.
Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat. 2002;246:1–190.
Ogden CL, Carroll M, Curtin L, et al. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA. 2010;303(3):242–9.
Breaux CW. Obesity surgery in children. Obes Surg. 1995;5(3):279–84.
Howe LD, Galobardes B, Sattar N, et al. Are there socioeconomic inequalities in cardiovascular risk factors in childhood, and are they mediated by adiposity? Findings from a prospective cohort study. Int J Obes (Lond). 2010;34(7):1149–59.
Broyles S, Katzmarzyk PT, Srinivasan SR, et al. The pediatric obesity epidemic continues unabated in Bogalusa, Louisiana. Pediatrics. 2010;125(5):900–5.
Swinburn BA. Commentary: closing the disparity gaps in obesity. Int J Epidemiol. 2009;38(2):509–11.
Gastrointestinal Surgery for Severe Obesity. NIH Consensus Statement 1991; 9(1):1-20.
Fried M, Ribaric G, Buchwald JN, et al. Metabolic surgery for the treatment of type 2 diabetes in patients <35kg/m2: an integrative review of early studies. Obes Surg. 2010;20(6):776–90.
Nguyen NT, Magno CP, Lane KT, et al. Association of hypertension, diabetes, dyslipidemia, and metabolic syndrome with obesity: findings from the National Health Nutrition Examination Survey, 1999 to 2004. J Am Coll Surg. 2008;207(6):928–34.
Razak F, Anand SS, Shannon H, et al. Defining obesity cut points in a multiethnic population. Circulation. 2007;115:2111–8.
Deurenberg P, Deurenberg-Yap M. Validity of body composition methods across ethnic population groups. Forum Nutr. 2003;56:299–301.
Saelens BE. Visceral fat is worth measuring and measuring well. Arch Pediatr Adolesc Med. 2008;162(5):491–2.
Misra A, Chowbey P, Makkar BM, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians of India. 2009;57:163–70.
World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications; part 1: diagnosis and classification of diabetes mellitus. Geneva: WHO Department of Non-communicable Disease Surveillance; 1999.
Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care. 2005;28(11):2745–9.
Grundy SM, Cleeman JI, Daniels SR et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement [published corrections appear in Circulation 2005; 112(17): e297 and 2005; 112(17): e298].
Braverman E, et al. PATH Foundation NY. Obesity under diagnosed when using body mass index. Presented April 23, 2010 at the American Association of Clinical Endocrinologists (AACE) 19th Annual Meeting & Clinical Congress, Boston, MA.
Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990–1998. Diabetes Care. 2000;23:1278–83.
Willett WC, Manson JE, Stampfer MJ, et al. Weight, weight change and coronary heart disease in women. JAMA. 1995;273:461–5.
Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37.
Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248–56.e5. review.
Christou NV. Impact of obesity and bariatric surgery on survival. World J Surg. 2009;33(10):2022–7.
Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621–32. review.
Sjöström L, Narbro K, Sjöström CD. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741–52.
Hayden MJ, Dixon ME, Dixon JB, et al. Perceived discrimination and stigmatisation against severely obese women: age and weight loss make a difference. Obes Facts. 2010;3(1):7–14.
Herpertz S, Kielmann R, Wolf AM, et al. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord. 2003;27:1300–14.
Deitel M. How much weight loss is sufficient to overcome major co-morbidities? Obes Surg. 2001;11:659.
Division of Nutrition, Physical Activity and Obesity, National Center for Chronic Disease Prevention and Health Promotion. Healthy weight: it’s not a diet, it’s a lifestyle. Feb 22, 2010. Accessible at: http://www.cdc.gov/healthyweight/index.html.
Astrup A. Dietary management of obesity. J Parenter Enteral Nutr. 2008;32(5):575–7.
Christiansen T, Brunn JM, Madsen EL, et al. Weight loss maintenance in severely obese adults after an intensive lifestyle intervention: 2- to 4-year follow-up. Obesity. 2007;15(2):413–20.
Goodrick GK, Foreyt JP. Why treatments for obesity don’t last. JAMA. 1991;91:1243–7.
Sharma M. Behavioral interventions for preventing and treating obesity in adults. Obes Rev. 2007;8:441–9.
Martins C, Strommen M, Stavne OA, et al. Bariatric surgery versus lifestyle interventions for morbid obesity—changes in body weight, risk factors and comorbidities at 1year. Obes Surg. 2011;21(7):841–9.
Avenell A, Brown TJ, Mcgee MA, et al. What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials. J Hum Nutr Diet. 2004;17:317–35.
Tsai AG, Wadden TA. Systematic review: an evaluation of major commercial weight loss programs in the United States. Ann Intern Med. 2005;142:56–66.
Wilding JPH. Treatment strategies for obesity. Obes Rev. 2007;8(s1):137–44.
Jeffery RW, Drewnowski A, Epstein LH, et al. Long-term maintenance of weight loss: current status. Health Psychol. 2000;19(1)(suppl):5–16.
Wadden TA, Crerand CE, Brock J. Behavioral treatment of obesity. Psychiatr Clin North Am. 2005;28(1):151–70.
Dansinger ML, Tabsioni A, Wong JB, et al. Meta-analysis: the effect of dietary counseling for weight loss. Ann Intern Med. 2007;147(1):41–50.
Anderson JW, Grant L, Gotthelf L, et al. Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program. Int J Obes. 2007;31(3):488–93.
Anderson JW, Conley SB, Nicholas AS. One hundred pound weight losses with an intensive behavioral program: changes in risk factors in 118 patients with long-term follow-up. Am J Clin Nutr. 2007;86(2):301–7.
Bray GA. Drug management in obesity. In: Buchwald H, Cowan SM, Pories WJ, editors. Surgical Management of Obesity. New York: Saunders; 2007. p. 73–82.
European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). http://www.ema.europa.eu/htms/general/contacts/CHMP/CHMP.html. Accessed 23 Feb 2012.
Wadden TA, Butryn ML, Wilson C. Lifestyle modification for the management of obesity. Gastroenterology. 2007;132(6):2226–38.
Luque CA, Rey JA. Sibutramine: a serotonin-norepinephrine reuptake inhibitor for the treatment of obesity. Ann Pharmacother. 1999;33(9):968–78.
Hvizdos KM, Markham A. Orlistat: a review of its use in the management of obesity. Drugs. 1999;58(4):743–60.
Pi-Sunyer F, Aronne LJ, Heshmati HM, et al. Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients—RIO-North America: a randomized controlled trial. J Am Med Assoc. 2006;295:761–75.
Garrow JS. Withdrawal of sibutramine. Magic bullets now controlled. BMJ. 2010;340:c1351.
Cummings D, Overduin J, Foster-Schubert KE, et al. Role of the bypassed proximal intestine in the anti-diabetic effects of bariatric surgery. Surg Obes Relat Dis. 2007;3(2):109–15.
Dixon JB, Strauss BJ, Laurie C, et al. Changes in body composition with weight loss: obese subjects randomized to surgical and medical programs. Obesity (Silver Spring, MD). 2007;15:1187–98.
Karlsson J, Taft C, Ryden A, et al. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes. 2007;31:1248–61.
Nguyen NT, Silver M, Robinson M, et al. Result of a national audit of bariatric surgery performed at academic centers: a 2004 University Health System Consortium Benchmarking Project. Arch Surg. 2006;141:445–9.
Pontiroli AE, Morabito A. Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg. 2011;253(3):484–7.
DeMaria EJ, Portenier D, Wolfe L. Obesity surgery mortality risk score: proposal for a clinically useful score to predict mortality risk in patients undergoing gastric bypass. Surg Obes Relat Dis. 2007;3:134–40.
Atkinson RL. Proposed standards for judging the success of the treatment of obesity. Ann Intern Med. 1993;119(7 Pt 2):677–80.
van Gemert WG, Adang EMM, Greve JWM, et al. Quality of life assessment of morbidly obese patients: effect of weight-reducing surgery. AmJ Clin Nutr. 1998;67:197–201.
Nguyen N, Varela EJ, Nguyen T, et al. Quality of life assessment in the morbidly obese. Obes Surg. 2006;16(5):531–3.
Apovian CM, Cummings S, Anderson W, et al. Best practice updates for multidisciplinary care in weight loss surgery. Obesity (Silver Spring). 2009;17(5):871–9.
Champion JK, Pories WJ. 2004 ASBS Consensus Conference. Centers of excellence for bariatric surgery. Surg Obes Relat Dis. 2005;1(2):148–51.
Pratt GM, Learn CA, Hughes GD, et al. Demographics and outcomes at American Society for Metabolic and Bariatric Surgery Centers of Excellence. Surg Endosc. 2009;23(4):795–9.
Martin M, Beekley A, Kjorstad R, et al. Socioeconomic disparities in eligibility and access to bariatric surgery: a national population-based analysis. Surg Obes Relat Dis. 2010;6(1):8–15.
Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361:445–54.
Afonso BB, Rosenthal R, Li KM, et al. Perceived barriers to bariatric surgery among morbidly obese patients. Surg Obes Relat Dis. 2010;6(1):16–21.
Fernandez Jr AZ, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg. 2004;239(5):698–702. discussion 702-3.
Livingston EH, Arterburn D, Schifftner TL, et al. National Surgical Quality Improvement Program analysis of bariatric operations: modifiable risk factors contribute to bariatric surgical adverse outcomes. J Am Coll Surg. 2006;203(5):625–33.
Arterburn D, Livingston EH, Schifftner T, et al. Predictors of long-term mortality after bariatric surgery performed in Veterans Affairs medical centers. Arch Surg. 2009;144(10):914–20.
Bein B, Scholz J. Anaesthesia for adults undergoing non-bariatric surgery. Best Pract Res Clin Anaesthesiol. 2011;25(1):37–51.
Papavramidis T, Kesisoglou I, Orailoglou V, et al. Mega-obese patients weighing more than 250kg: a problematic group. Acta Chir Belg. 2009;109(1):61–4.
Iannelli A, Schneck AS, Dahman M, et al. Two-step laparoscopic duodenal switch for superobesity: a feasibility study. Surg Endosc. 2009;23(10):2385–9.
El-Koofy NM, Anwar GM, El-Raziky MS, et al. The association of metabolic syndrome, insulin resistance and non-alcoholic fatty liver disease in overweight/obese children. Saudi J Gastroenterol. 2012;18(1):44–9.
Johnson WD, Kroon JJ, Greenway FL, et al. Prevalence of risk factors for metabolic syndrome in adolescents: National Health and Nutrition Examination Survey (NHANES), 2001–2006. Arch Pediatr Adolesc Med. 2009;163(4):371–7.
Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA. 2003;289(14):1813–9.
Papavramidis ST, Kotidis EV, Gamvros O. Prader–Willi syndrome-associated obesity treated by biliopancreatic diversion with duodenal switch. Case report and literature review. J Pediatr Surg. 2006;41:1154–8.
O'Brien PE, Sawyer SM, Laurie C, et al. Laparoscopic adjustable gastric banding in severely obese adolescents: a randomized trial. JAMA. 2010;303(6):519–26.
Inge TH, Jenkins TM, Zeller M, et al. Baseline BMI is a strong predictor of nadir BMI after adolescent gastric bypass. J Pediatr. 2010;56(1):103–8.
Woolford SJ, Clark SJ, Gebramariam A, et al. To cut or not to cut: physicians’ perspectives on referring adolescents for bariatric surgery. Obes Surg. 2010;20(7):937–42.
Clinical Issues Committee, ASMBS. 2009 ASMBS Position Statement on emerging endosurgical interventions for treatment of obesity. Accessible: http://www.asmbs.org/Newsite07/resources/emerging_tech_position.pdf. Accessed 23 Feb 2012.
Schauer P, Chand B, Brethauer S. New applications for endoscopy: the emerging field of endoluminal and transgastric bariatric surgery. Surg Endosc. 2007;21:347–56.
Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3:145–6.
Melissas J, Mouzas J, Filis D, et al. The intragastric balloon—smoothing the path to bariatric surgery. Obes Surg. 2006;16:897–902.
Cremieux PY, Buchwald H, Shikora SA, et al. A study on the economic impact of bariatric surgery. Am J Manag Care. 2008;14(9):589–96.
Meshkinpour H, Hsu D, Farivar S. Effect of gastric bubble as a weight reduction device: a controlled, crossover study. Gastroenterology. 1988;95:589–92.
Tsesmeli N, Coumaros D. Review of endoscopic devices for weight reduction: old and new balloons and implantable prostheses. Endoscopy. 2009;41(12):1082–9.
Imaz I, Martínez-Cervell C, García-Alvarez EE, et al. Safety and effectiveness of the intra-gastric balloon for obesity: a meta-analysis. Obes Surg. 2008;18:841–6.
Coté GA, Edmundowicz SA. Emerging technology: endoluminal treatment of obesity. Gastrointest Endosc. 2009;70(5):991–9. Review.
Sallet JA, Marchesini JB, Paiva DS, et al. Brazilian multicenter study of the intragastric balloon. Obes Surg. 2004;14(7):991–8.
Busetto L, Segato G, De Luca M, et al. Preoperative weight loss by intragastric balloon in super-obese patients treated with laparoscopic gastric banding: a case–control study. Obes Surg. 2004;14(5):671–6.
Busetto L, Enzi G, Inelmen EM, et al. Obstructive sleep apnea syndrome in morbid obesity: effects of intragastric balloon. Chest. 2005;128(2):618–23.
Musella M, Milone M, Bellini M, et al. The potential role of intragastric balloon in the treatment of obese-related infertility: personal experience. Obes Surg. 2011;21(4):426–30.
Loffredo A, Cappuccio M, de Luca M, et al. Three years experience with the new intragastric balloon, and a preoperative test for success with restrictive surgery. Obes Surg. 2001;11(3):330–3.
Gersin KS, Keller JE, Stefanidis D, et al. Duodenal-jejunal bypass sleeve: a totally endoscopic device for the treatment of morbid obesity. Surg Innov. 2007;14:275–8.
Aguirre V, Stylopoulos N, Grinbaum R, et al. An endoluminal sleeve induces substantial weight loss and normalizes glucose homeostasis in rats with diet-induced obesity. Obesity (Silver Spring). 2008;16(12):2685–92.
Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23(3):650–6.
Brethauer SA, Hammel JP, Schauer PR. Systematic review of sleeve gastrectomy as staging and primary bariatric procedure. Surg Obes Relat Dis. 2009;5(4):469–75.